Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Related news

STIMNeuronetics2026-11-04 12:50 EST

Neuronetics Reports Third Quarter 2026 Financial and Operating Results

STIMNeuronetics2026-10-21 12:30 EST

Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call

ANGOAngioDynamics2026-11-06 23:00 EST

AngioDynamics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PLSEPulse Biosciences2026-10-09 20:05 EST

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DCTHDelcath Systems2026-09-11 20:01 EST

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RXSTRxSight2026-10-24 00:00 EST

RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

View all latest news

Neuronetics

Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders. It combines a proprietary treatment system with a national network of clinics that directly delivers therapy. NeuroStar Advanced Therapy NeuroStar uses...